CJC-1295 No DAC 10mg

CJC-1295 No DAC Peptide is the research community's shorthand for CJC-1295 No DAC - the same compound listed on this page. If you searched for CJC-1295 No DAC Peptide, Mod GRF 1-29, Modified GRF, this is that compound: CJC-1295 No DAC supplied as a 10mg lyophilised vial, third-party tested with a batch-specific Certificate of Analysis. For in-vitro research use only.

CJC-1295 No DAC is a synthetic peptide supplied by Pillar Research as Lyophilised powder for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. In research communities it is also searched for as Mod GRF 1-29, Modified GRF - all refer to the same compound.

Studied for how growth-hormone release is triggered in laboratory models. More precisely, the GHRH receptor over a shorter research window of hours (Mod GRF 1-29), compared with days for the DAC-conjugated form. CJC-1295 No DAC is supplied strictly as Research Use Only material for in-vitro laboratory work.

Studied for how growth-hormone release behaves in laboratory models. More precisely, muscle growth and recovery, over a shorter research window than the DAC form due to its shorter active duration.

CJC-1295 No DAC is commonly referred to as CJC-1295 No DAC Peptide in research communities and is sometimes searched for as Mod GRF 1-29, Modified GRF - all refer to the same compound.

You are looking at the evidence the same way researchers do: by compound, batch and method, not by marketing claim. CJC-1295 No DAC is supplied as a research-use compound for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. Each Pillar Research batch is third-party tested by HPLC and mass spectrometry, with the batch-specific Certificate of Analysis published for review before ordering - that certificate is the research record to judge.

Pillar Research does not provide dosing, reconstitution-for-use, or administration guidance for any compound - this is a deliberate policy, not an oversight, consistent with the Research Use Only framework under which CJC-1295 No DAC is supplied. Research protocols vary by study design and institution. Consult the peer-reviewed literature for the compound (see the references linked on this page) or a qualified research supervisor for protocol-specific guidance.

CJC-1295 No DAC (10mg) is available through Pillar Research, a trusted supplier for research peptides, with fast domestic shipping to all states and territories. Every vial is dispatched from domestic Australian stock the same business day - no customs delays, no international freight uncertainty. The batch-specific Certificate of Analysis is available to review before ordering. See our supplier guide at /buy-peptides-australia for the checklist to apply to any Australian supplier.

Pillar Research does. Each CJC-1295 No DAC batch is tested by Janoshik Analytical, an independent third-party laboratory, and the batch-specific Certificate of Analysis is published on this page before you order. Stock is held in Australia and dispatched the same business day.

CJC-1295 No DAC (10mg) is priced at A$99.99 per vial at Pillar Research. Yes. CJC-1295 No DAC is in stock at Pillar Research and orders placed before the dispatch cut-off leave from Australian stock the same business day. Batch Certificates of Analysis are available in our CoA library.

CJC-1295 No DAC is a research-use compound supplied for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. Purchasers confirm the compound is intended for in-vitro research use at checkout.

Ordering is straightforward - add CJC-1295 No DAC 10mg (CJC-1295 No DAC Peptide) to your cart on this page and complete checkout. All orders are fulfilled from domestic Australian stock and shipped with tracking the same business day when placed before the cut-off. A batch-specific Certificate of Analysis is included with every order.

Yes. Each released CJC-1295 No DAC 10mg (CJC-1295 No DAC Peptide) vial is linked to a batch-specific Certificate of Analysis (COA) so the stated purity, identity and batch record can be reviewed before ordering. CJC-1295 No DAC 10mg (CJC-1295 No DAC Peptide) is listed at 99.815% purity. Each released batch is independently analysed by HPLC for chromatographic purity and by mass spectrometry for identity.

No. CJC-1295 No DAC is not listed on the Australian Register of Therapeutic Goods (ARTG), so it is not stocked by Australian retail pharmacies and is not a therapeutic good under the Therapeutic Goods Act 1989 (Cth). Compounding pharmacies cannot supply it either - there is no approved commercial or pharmacy release to compound from. Pillar Research supplies it as Research Use Only material for in-vitro laboratory work, not for human or animal use, and it should not be sought as a consumer product.

CJC-1295 No DAC may be lawfully supplied and held in Australia as Research Use Only material for in-vitro laboratory and educational research. That is a different status from approval for human use, which it does not have. Purchasers confirm they are a qualified researcher or acting for a licensed research facility, and are responsible for the lawful handling, storage and use of the material.